SU1604383A1 - Method of treating ischemic disease of heart - Google Patents

Method of treating ischemic disease of heart Download PDF

Info

Publication number
SU1604383A1
SU1604383A1 SU813377957A SU3377957A SU1604383A1 SU 1604383 A1 SU1604383 A1 SU 1604383A1 SU 813377957 A SU813377957 A SU 813377957A SU 3377957 A SU3377957 A SU 3377957A SU 1604383 A1 SU1604383 A1 SU 1604383A1
Authority
SU
USSR - Soviet Union
Prior art keywords
complications
treatment
blood
heart
light guide
Prior art date
Application number
SU813377957A
Other languages
Russian (ru)
Inventor
Евгений Николаевич Мешалкин
Владислав Сергеевич Сергиевский
Александра Михайловна Шургая
Лидия Антоновна Кремлева
Владимир Николаевич Захаров
Ирина Анатольевна Бахтина
Владимир Алексеевич Байков
Галина Александровна Корепанова
Людмила Никитична Русяева
Леонид Анатольевич Девятьяров
Original Assignee
Научно-исследовательский институт патологии кровообращения
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Научно-исследовательский институт патологии кровообращения filed Critical Научно-исследовательский институт патологии кровообращения
Priority to SU813377957A priority Critical patent/SU1604383A1/en
Application granted granted Critical
Publication of SU1604383A1 publication Critical patent/SU1604383A1/en

Links

Landscapes

  • Radiation-Therapy Devices (AREA)

Abstract

Изобретение относитс  к медицине, а именно к кардиологии, и может быть использовано при лечении ишемической болезни сердца. Цель изобретени  - предупреждение осложнений ишемии миокарда путем стабилизации энергетического баланса миокарда. Дл  этого в локтевую вену через пункционную иглу ввод т кварцевый световод, подключают его к гелий-неоновому лазеру с длиной волны 6328 А и облучают кровь в течение 30 мин. Курс лечени  включает проведение 3-5 сеансов облучени  крови. Способ позвол ет стабилизировать состо ние больного и предупредить развитие осложнений ишемии миокарда.The invention relates to medicine, namely cardiology, and can be used in the treatment of ischemic heart disease. The purpose of the invention is the prevention of complications of myocardial ischemia by stabilizing the energy balance of the myocardium. To do this, a quartz light guide is inserted into the cubital vein through a puncture needle, connected to a helium-neon laser with a wavelength of 6328 A and irradiated blood for 30 minutes. The course of treatment includes 3-5 sessions of blood irradiation. The method allows to stabilize the patient's condition and prevent the development of complications of myocardial ischemia.

Description

Изобретение относитс  к медицине, а именно к кардиологии.The invention relates to medicine, namely cardiology.

Цель изобретени  - предупреждение осложнений путем стабилизации энергетического баланса миокарда.The purpose of the invention is the prevention of complications by stabilizing the energy balance of the myocardium.

Способ осуществл ют следующим образом .The method is carried out as follows.

Через пункционную иглу в локтевую вену ввод т кварцевый световод, подключают световод к гелий-неоновому лазеру сThrough the puncture needle, a quartz light guide is inserted into the cubital vein, the light guide is connected to a helium-neon laser with

о about

ДЛИНОЙ волны 6328 А, облучают кровь в течение 30 мин. Курс лечени  включает 3-5 сеансов с интервалами 48 ч. При необходимости через 3-4 мес. курс лечени  повтор ют .A long wavelength of 6328 A, irradiate the blood for 30 minutes. The course of treatment includes 3-5 sessions at intervals of 48 hours. If necessary, in 3-4 months. the treatment is repeated.

Пример. Больной К., 43 года. Диагноз: ишемическа  болезнь сердца, стенокарди  напр жени  и поко , прстинфарктный кардиосклероз . Длительное стационарное лечение без эффекта . Через локтевую вену вункционно введен лазерный световод.Example. Patient K., 43 years old. Diagnosis: ischemic heart disease, angina, stress, restraint, cardiac sclerosis. Prolonged hospital treatment without effect. Through the ulnar vein, a laser light guide was inserted in the function.

Проведено облучение крови гелий-неонооHelium-neonoo blood was irradiated

вым лазером с длиной волны 6328 А в течение 30 мин. Курс лечени  составил 3 сеанса облучени  крови. К моменту выписки отмечено значительное улучшение самочувстви , уменьшение интенсивности и частоты загрудинных болей, повышение физической активности, а также снижение количества принимаемого нитроглицерина. На ЭКГ - синусовый ритм с частотой сердечных сокращений 80 в мин, улучшение кровоснабжени  миокарда левого желудочка. При контрольном осмотре через 3 мес состо ние вполне удов летворительное.laser with a wavelength of 6328 A for 30 minutes. The course of treatment was 3 sessions of blood irradiation. By the time of discharge, there was a significant improvement in well-being, a decrease in the intensity and frequency of chest pains, an increase in physical activity, and a decrease in the amount of nitroglycerin taken. On the ECG - sinus rhythm with a heart rate of 80 min, improving blood supply to the left ventricular myocardium. At the control examination after 3 months, the condition is quite satisfactory.

По предлагаемому способу пролечено 600 больных с хорошим эффектом.The proposed method treated 600 patients with good effect.

Способ рекомендован дл  клинического применени .The method is recommended for clinical use.

Claims (1)

Формула изобретени Invention Formula Способ лечени  ишемической болезни сердца, включающий воздействие на кровь.A method for the treatment of coronary heart disease, including effects on the blood. оabout СА 00 СОSA 00 CO отличающийс  тем, что, с целью °characterized in that, in order to предупреждени  осложнений путем стаби-излучением с длиной волны 6328 А в течелизации энергетического баланса миокар- е 30 мин, при этом лазерный световодprevention of complications by means of stabilization radiation with a wavelength of 6328 A in checking the energy balance of myocardium for 30 minutes, while the laser light guide да, на гомеостаз воздействуют лазернымввод т внутривенно.yes, homeostasis is affected by laser injection intravenously.
SU813377957A 1981-12-11 1981-12-11 Method of treating ischemic disease of heart SU1604383A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU813377957A SU1604383A1 (en) 1981-12-11 1981-12-11 Method of treating ischemic disease of heart

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU813377957A SU1604383A1 (en) 1981-12-11 1981-12-11 Method of treating ischemic disease of heart

Publications (1)

Publication Number Publication Date
SU1604383A1 true SU1604383A1 (en) 1990-11-07

Family

ID=20990953

Family Applications (1)

Application Number Title Priority Date Filing Date
SU813377957A SU1604383A1 (en) 1981-12-11 1981-12-11 Method of treating ischemic disease of heart

Country Status (1)

Country Link
SU (1) SU1604383A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007735A1 (en) * 1995-08-22 1997-03-06 Board Of Regents, The University Of Texas System A maneuverable electrophysiology catheter for percutaneous or intraoperative ablation of cardiac arrhythmias

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Стенокарди . Под ред. Д.Джулиана. Москва:. Медицина, 1980, с.263-274. *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007735A1 (en) * 1995-08-22 1997-03-06 Board Of Regents, The University Of Texas System A maneuverable electrophysiology catheter for percutaneous or intraoperative ablation of cardiac arrhythmias
US5824005A (en) * 1995-08-22 1998-10-20 Board Of Regents, The University Of Texas System Maneuverable electrophysiology catheter for percutaneous or intraoperative ablation of cardiac arrhythmias
US6143019A (en) * 1995-08-22 2000-11-07 Board Of Regents, The University Of Texas System Method for emitting therapeutic energy within tissue
US6736808B1 (en) 1995-08-22 2004-05-18 Massoud Motamedi Apparatus for emitting therapeutic energy within tissue

Similar Documents

Publication Publication Date Title
Kelly et al. Thioridazine hydrochloride (Mellaril): its effect on the electrocardiogram and a report of two fatalities with electrocardiographic abnormalities
TAKAHASHI et al. On the site of action of γ-aminobutyric acid on blood pressure
BROWN et al. Cardiovascular changes associated with electroconvulsive therapy in man
SU1604383A1 (en) Method of treating ischemic disease of heart
Neumeister et al. Advances in hypoxyradiotherapy
RU2082466C1 (en) Method for treating cardiac ischemia disease
Long et al. Effect of Some Sulfhydryl-containing Substances on the Toxicity of an Organic Mercurial Compound
SU1680218A1 (en) Method of rehabilitation of patients got over myocardial infarction
RU1827272C (en) Method of lung tuberculosis treatment
SU827081A1 (en) Method of treating vasomotor headache
Chen et al. Effects of acupuncture on tissue-oxygenation of the rat brain
Perese et al. Autonomic regulatory mechanism in human spinal cord: I. Blood pressure responses and results of square wave stimulation in patients subjected to spinothalamic tractotomy
RU2018329C1 (en) Method for treatment of diabetes mellitus at children
SU1312786A1 (en) Method of treating arrythmia in myocardium infarction cases
RU2192836C2 (en) Method for evaluating hyperbaric oxygenation treatment effectiveness
RU1810066C (en) Acute cardiac insufficiency syndrome treatment method
RU2174023C1 (en) Method for treating the cases of cardiac ischemia disease
RU1797910C (en) Method for treating ventricular extrasystole
RU2071756C1 (en) Method for treating cardiac rhythm disorders
RU2218141C1 (en) Method for controlling the safety of hyperbaric oxygenation procedure
SU1392700A1 (en) Method of treating myocardial infraction patients
RU2160616C2 (en) Method for treating cardiac rhythm disorders
RU2110297C1 (en) Method for treating the patients possessing sinus node asthenia
RU1799591C (en) Method for essential hypertension treatment
RU2038107C1 (en) Method for treating the cases of hypertension disease